PATH | VRL
Menu

Find resources

Total results with these characteristics: 155

Disease: Influenza

Page 7 of 8
The State of Vaccine Confidence: 2015

This report aims to build understanding of the global picture of public confidence in vaccines by analyzing vaccine confidence issues and paths to their resolution over the past decade. It presents options for monitoring and measuring public …

Author: London School of Hygiene & Tropical Medicine

Publication date: 2015

Strengthening Maternal Immunisation to Improve the Health of Mothers and Infants

Innovative approaches to maternal immunization have the potential to decrease serious morbidity and mortality not only in the mother, but also in the baby who is not yet able to immunologically respond to most vaccines. This article, published in …

Author: Abramson JS, Mason E

Publication date: 2016

Subunit Influenza Vaccines Produced From Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity

This study, published in the Journal of Infectious Diseases, assessed the safety, reactogenicity, and immunogenicity of an injectable cell culture-derived influenza vaccine, compared with those of an injectable egg-based trivalent inactivated …

Author: Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ

Publication date: 2009

Summary of Vaccine Stability Data

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format in both …

Author: PATH, Working in Tandem Ltd.

Publication date: 2012

Supporting Influenza Vaccine Production in Vietnam

This fact sheet describes a project that PATH is implementing in collaboration with the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project is supporting the enhancement of …

Author: PATH

Publication date: 2016

Survey of Distribution of Seasonal Influenza Vaccine Doses in 201 Countries (2004–2015): The 2003 World Health Assembly Resolution on Seasonal Influenza Vaccination Coverage and the 2009 Influenza Pandemic Have Had Very Little Impact on Improving Influenza Control and Pandemic Preparedness

This article, published in Vaccine, assesses progress made toward the 2003 World Health Assembly (WHA) vaccination coverage target for influenza vaccines. Because there is no international monitoring system for influenza vaccination …

Author: Palache A, Abelin A, Hollingsworth R, et al.

Publication date: 2017

TechNet Resource Library

This website provides an online repository of useful journal articles, documents, tools, websites, and other immunization resources. Users are able to search by keyword or browse the collection by category, disease, or other tag. Members of the …

Author: Technical Network for Strengthening Immunization Services

Temperature Sensitivity of Vaccines

This document addresses issues regarding potential exposure of temperature-sensitive vaccines to freezing temperatures and provides updated information on vaccine vial monitors, as well as a discussion of future advances in cold chain technology.

Author: World Health Organization

Publication date: 2006

Toward a Universal Influenza Virus Vaccine: Prospects and Challenges

This article, published in Annual Review of Medicine, summarizes advances in the field of universal influenza vaccine development. It focuses on novel vaccine designs that have yielded promising preclinical and clinical data. ABSTRACT ONLY. (Learn …

Author: Pica N, Palese P

Publication date: 2013

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

This article, published by The New England Journal of Medicine, details the findings of a single-center study in the United Kingdom to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted and …

Author: Clark TW, Pareek M, Hoschler K, et al.

Publication date: 2009

Trial of Influenza A(H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine -- Preliminary Report

This article, published in The New England Journal of Medicine, describes the methods, results, and conclusions from a single-center study to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine. The study, conducted in the …

Author: Clark TW, Pareek M, Hoschler K, et al.

Publication date: 2009

Understanding Influenza Vaccine Effectiveness in Senegal

This fact sheet describes a Phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, …

Author: PATH

Publication date: 2011

Understanding Influenza Vaccine Performance Among Children in Senegal

This fact sheet describes a Phase 2 influenza vaccine clinical study that PATH and its partners are conducting in Senegal. The study seeks to better understand the performance of seasonal influenza vaccines in a tropical, low-resource region of the …

Author: PATH

Publication date: 2013

Understanding Thimerosal, Mercury, and Vaccine Safety

This fact sheet explains what thimerosal is and why it is used as a preservative in some multi-dose vials of influenza vaccine, and highlights conclusions from studies examining thimerosal safety in vaccines.

Author: US Centers for Disease Control and Prevention

Publication date: 2012

Universal Influenza Vaccines: Shifting to Better Vaccines

This article, published in Vaccine, provides an overview of currently available influenza vaccines and their limitations, and also outlines current efforts to develop a broadly protective, universal influenza vaccine. It also highlights general …

Author: Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ

Publication date: 2016

Unprotected People Reports

This web page contains real-life accounts of people who have suffered or died from vaccine-preventable diseases, including compelling personal testimonies, remembrances, case reports, and newspaper articles.

Author: Immunization Action Coalition

US Department of Health and Human Services and PATH: Partnering to Protect and Improve Global Health

PATH and the US Department of Health and Human Services (HHS) work together to improve global health around the world. This fact sheet highlights PATH projects—including work to develop a thermostable vaccine for H1N1 influenza; ROTAVAC®, a new …

Author: PATH

Publication date: 2014

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

This article, published in the New England Journal of Medicine, describes a multinational, Phase 3, observer-blinded study evaluating the efficacy of quadrivalent influenza vaccine (QIV) among children three to eight years of age. From the study …

Author: Jain VK, Rivera L, Zama Khalequ, et al.

Publication date: 2013

Vaccine Information Statements

This page contains vaccine information statements for a variety of immunizations, which are published by the US Centers for Disease Control and Prevention. This web page also includes links to translations of the statements to many languages other …

Author: Immunization Action Coalition

Vaccine Information Statements

Vaccine Information Statements (VISs) are information sheets used in the United States (US) that explain both the benefits and risks of a vaccine to vaccine recipients. US federal law requires that healthcare staff provide a VIS to a patient, …

Author: US Centers for Disease Control and Prevention

Page 7 of 8